Pruritus is associated with severely impaired quality of life in patients with primary sclerosing cholangitis

Review article: controversies in the management of primary biliary cirrhosis and primary sclerosing cholangitis

(2013) T. H. Karlsen et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

FUT2 and FUT3 genotype determines CA19-9 cut-off values for detection of cholangiocarcinoma in patients with primary sclerosing cholangitis

(2013) Andreas Wannhoff et al.   JOURNAL OF HEPATOLOGY

Health-related quality of life, depression, and anxiety in patients with autoimmune hepatitis

(2013) Christoph Schramm et al.   JOURNAL OF HEPATOLOGY

Factors That Reduce Health-Related Quality of Life in Patients With Primary Sclerosing Cholangitis

(2012) Maria Benito de Valle et al.   Clinical Gastroenterology and Hepatology

Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventions

(2012) Andreas E. Kremer et al.   HEPATOLOGY

Non-IBD immunological diseases are a risk factor for reduced survival in PSC

(2012) Christian Rupp et al.   LIVER INTERNATIONAL

Endoscopic dilation of dominant stenoses in primary sclerosing cholangitis: outcome after long-term treatment

(2010) Daniel N. Gotthardt et al.   GASTROINTESTINAL ENDOSCOPY

Limitations of the MELD score in predicting mortality or need for removal from waiting list in patients awaiting liver transplantation

(2009) Daniel Gotthardt et al.   BMC GASTROENTEROLOGY

Influence of dominant bile duct stenoses and biliary infections on outcome in primary sclerosing cholangitis

(2009) Gerda Rudolph et al.   JOURNAL OF HEPATOLOGY